Clinical Trial Update: Paroxetine-CR to Treat Post-Traumatic Stress Disorder (PTSD) Symptomatic After Initial Exposure Therapy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating Paroxetine-CR for post-traumatic stress disorder symptoms after initial exposure therapy has completed. The trial ex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Paroxetine-CR (paroxetine)

Snippet

Sponsor: Duke University | Conditions: Stress Disorders, Post-Traumatic | Phase 2, Phase 3 | Status: COMPLETED